Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CXCR5 | P32302 | 1/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.31 |
| ▸ | CDC25A | P30304 | 1/20 | 0.31 |
| ▸ | CDC25B | P30305 | 1/20 | 0.31 |
| ▸ | CDC25C | P30307 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 2/20 | 0.30 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6792781 | 0.92 | ALDH1A1 (0.34) | ALDH1A1MAPTTDP1USP2HPGD | |
| SCHEMBL14706340 | 0.89 | MCHR1 (0.32) | ALDH1A1MAPTMCHR1CDC25ACDC25B | |
| SCHEMBL13572446 | 0.86 | MCHR1 (0.35) | ALDH1A1MAPTMCHR1CDC25ACDC25B | |
| SCHEMBL14706342 | 0.83 | MEN1 (0.33) | ALDH1A1MAPTMCHR1KDM4ELMNA | |
| SCHEMBL6787896 | 0.80 | LTA4H (0.40) | MAPTMCHR1PPARGPPARDPPARA | |
| SCHEMBL14706337 | 0.80 | THRA (0.35) | ALDH1A1MAPTTDP1KDM4ELMNA | |
| SCHEMBL13572449 | 0.78 | MAPT (0.36) | ALDH1A1MAPTMCHR1CDC25ACDC25B | |
| SCHEMBL15965787 | 0.75 | ALDH1A1 (0.38) | ALDH1A1MAPTKDM4ELMNANPSR1 | |
| SCHEMBL14827382 | 0.75 | MAPT (0.35) | ALDH1A1MAPTTDP1KDM4ELMNA | |
| SCHEMBL14827380 | 0.75 | MAPT (0.35) | ALDH1A1MAPTTDP1KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6806368-B2 | FOR ELECTRONIC, OPTOELECTRONIC AND PHOTONIC APPLICATIONS, FOR COLORATION OF MACROMOLECULAR ORGANIC AND OF INORGANIC MATERIALS | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-19 | — | — | US | disclosed |
| US-20030181721-A1 | Liquid crystalline 3,4:9,10-perylenetetacarbocylic acid diimides | BASF AKTIENGESELLSCHAFT (DE) | 2003-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181721-A1 | Liquid crystalline 3,4:9,10-perylenetetacarbocylic acid diimides | CCR9, CLTA, HAO2 | ALDH1A1 1393/4885MAPT 2542/4885TDP1 3774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.